|
CN112274493A
|
|
Preparation method of pipera cypress xili capsule
|
|
CN112006995A
|
|
Preparation method of hydrobromic acid vortioxetine tablet
|
|
CN111973566A
|
|
Sofosbuvir tablet
|
|
WO2021008512A1
|
|
Compound as nmt inhibitor and use thereof
|
|
CN111686083A
|
|
Ilaprazole enteric-coated tablet
|
|
WO2020233713A1
|
|
Application of heterocyclic compound and salt thereof
|
|
CN111440158A
|
|
Novel crystal form of brexpiprazole hydrochloride and preparation method thereof
|
|
WO2020192637A1
|
|
Brd4 inhibitor compound in solid form and preparation method therefor and application thereof
|
|
CN111297823A
|
|
Preparation method of oseltamivir phosphate capsule
|
|
WO2020173495A1
|
|
Salt of aldose reductase inhibitor, and preparation method and application thereof
|
|
WO2020143793A1
|
|
Salts of heterocyclic compound and use thereof
|
|
WO2020143781A1
|
|
Crystal form of heterocyclic compound as crth2 receptor antagonist
|
|
CN111000812A
|
|
Preparation method of lacosamide tablets
|
|
CN111100178A
|
|
Preparation method of medicinal-grade cholesterol sodium sulfate
|
|
CN111265480A
|
|
Epirubicin liposome and preparation method thereof
|
|
CN110927322A
|
|
Detection method of agastache rugosus healthy energy mixture
|
|
CN110606846A
|
|
Tofacitinib citrate impurity and analysis method and application thereof
|
|
KR20210034058A
|
|
Salts of LSD1 inhibitors and crystalline forms thereof
|
|
CN110283122A
|
|
A kind of high-purity logical sequence cuts down the preparation method for Buddhist nun and its salt
|
|
CN110343111A
|
|
Preparation method of tofacitinib citrate
|
